View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Atezolizumab 1680, Bladder Cancer, First Line
Protocol-ID: 1659 V1.0 (Mini), ATEZ1680, Bladder Ca, first-lineIndication(s)
- Bladder Cancer (PD-L1 with CPS from 10); ICD-10 C67.-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 13.11.2020